Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

Peer Review reports

Original Submission
13 Apr 2004	Submitted	Original manuscript
3 May 2004	Reviewed	Reviewer Report - Thomas Seufferlein
11 May 2004	Reviewed	Reviewer Report - Ullrich Graeven
14 Jun 2004	Author responded	Author comments - Markus Moehler
Resubmission - Version 2
14 Jun 2004	Submitted	Manuscript version 2
16 Jul 2004	Author responded	Author comments - Markus Moehler
Resubmission - Version 3
16 Jul 2004	Submitted	Manuscript version 3
Resubmission - Version 4
	Submitted	Manuscript version 4
16 Jul 2004	Author responded	Author comments - Markus Moehler
Resubmission - Version 5
16 Jul 2004	Submitted	Manuscript version 5
Publishing
20 Jul 2004	Editorially accepted
20 Jul 2004	Article published	10.1186/1471-2407-4-38

Back to article page